Showing results (81-90 of 401) with videos related to
Sort By:
Pageof 41
BMC Medicine|March 17, 2015
The National Institutes of Health and guidance for reporting preclinical researchDavid Moher, Marc Avey, Gerd Antes, et al.BMC Medicine|April 19, 2015
Erratum: The National Institutes of Health and guidance for reporting preclinical researchDavid Moher, Marc Avey, Gerd Antes, et al.Plos One|June 15, 2017
Did the reporting of prognostic studies of tumour markers improve since the introduction of REMARK guideline? A comparison of reporting in published articlesPeggy Sekula, Susan Mallett, Douglas G Altman, et al.Lancet (London, England)|May 22, 2002
Survival plots of time-to-event outcomes in clinical trials: good practice and pitfallsStuart J Pocock, Tim C Clayton, Douglas G AltmanBMJ Open|August 27, 2013
Incorporation of assessments of risk of bias of primary studies in systematic reviews of randomised trials: a cross-sectional studySally Hopewell, Isabelle Boutron, Douglas G Altman, et al.JAMA|April 24, 2019
Reporting of Multi-Arm Parallel-Group Randomized Trials: Extension of the CONSORT 2010 StatementEdmund Juszczak, Douglas G Altman, Sally Hopewell, et al.Medicina Clinica|February 9, 2006
[The CONSORT statement for cluster randomised trials]Marion K Campbell, Diana R Elbourne, Douglas G Altman, et al.Journal of the National Cancer Institute|January 10, 2008
Visualizing length of survival in time-to-event studies: a complement to Kaplan-Meier plotsPatrick Royston, Mahesh K B Parmar, Douglas G AltmanJAMA|May 27, 2010
Reporting and interpretation of randomized controlled trials with statistically nonsignificant results for primary outcomesIsabelle Boutron, Susan Dutton, Philippe Ravaud, et al.European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|July 19, 2014
Major geographical variations in elective coronary revascularization by stents or surgery in EnglandSheharyar S Baig, Douglas G Altman, David P TaggartPageof 41